Day 1 - Monday 15th June - CEST Time Zone
- Discussing the MDR/IVDR proposal -moving MDAI from Section A to Section B of Annex I
- Extended grace periods under the Digital Omnibus on AI - What do the new timelines mean for compliance planning?
- Arne Sunaert - Inspector Medical Device Software, FAMHP
- Jamie Gallagher - Partner, Mason Hayes & Curran
Exploring the importance of explainable AI in building trust among stakeholders by making AI decisions more transparent and understandable.
Addressing the growing demand for explainability in AI to meet regulatory requirements and ensure ethical decision-making in critical applications.
Discussing tools, techniques, and challenges in integrating explainable AI into real-world systems without compromising performance.
- Stephen Gilbert - Professor of Medical Device Regulatory Science, Else Kröner Fresenius Center for Digital Health, Technische Universität Dresden
- Vanda Almeida - Responsible AI Clinical Lead, Philips
- Ebube Ogbuagu - Medical Doctor, Royal Derby Hospital, NHS/ Committee Expert AI Airlock, MRHA
Exploring how AI drift impacts the accuracy and reliability of medical devices over time and the need for proactive monitoring strategies.
Evolving Post-Market Surveillance - addressing the role of PMS in detecting and mitigating AI drift through continuous monitoring, real-world data validation, and performance assessments.
- Stephanie Berger - Director Global PMS, Philips
Defining the Gray Zone - examining the challenges of regulating AI-enabled medical devices and their convergence with non-device technologies.
Exploring existing and emerging regulatory approaches to address the blurred lines between AIeMD and non-device solutions.
Highlighting the impact of this convergence on manufacturers, regulators, and healthcare providers, with strategies to navigate compliance and innovation.
- Rebecca Mathias - Research Associate, Medical Device Regulatory Science Group, Else Kröner Fresenius Center for Digital Health
- Leo Hovestadt - Director Governmental Affairs EU, Elekta
- An overview of the key features of new EU product liability framework, with a focus on new legal risks for software developers.
- An understanding of the growing role of product safety compliance in product liability litigation.
- An update on transposition across the EU, and how to prepare for claims alleging harm caused by SaMD and AI.
- Jamie Gallagher - Partner, Mason Hayes & Curran
- Reviewing key insights gained from data collection requirements under the AI Act and their implications for compliance.
Addressing practical obstacles in meeting data collection standards, including transparency, quality, and governance.
Exploring how organizations can adapt their data strategies to align with evolving requirements and ensure long-term compliance.
- Petr Brat'ka - Preclinical Evaluation Manager, Czech Metrology Institute
For more information, please contact Neha Singh at niha.singh@informa.com
Sharing first-hand experiences of SMEs in preparing for compliance, including resource and knowledge gaps.
Offering actionable steps and best practices for SMEs to meet the EU AI Act deadline effectively.
- Leon Doorn - Chair Medical Device / AI Working Group, NEN (Dutch Standardisation Institute)
